Q&A: COVID-19 pandemic linked to drop in colorectal cancer screenings

Colorectal cancer screening rates in recent years have significantly decreased in at-risk groups such patients aged 50 to 52 years and patients under 50 years with Crohn’s disease and ulcerative colitis, according to data collected by the Blue Cross Blue Shield Association and reported in The Health of America report, Rise in Chronic Conditions is Putting More Americans at risk for Colorectal Cancer.COVID-19 has further caused the colorectal cancer screenings to decline.Healio Gastroenterology spoke with Vincent Nelson, MD, vice president, medical affairs and interim chief medicalRead More

Share on facebook
Share on twitter
Share on linkedin